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A B S T R A C T
Previous studies have shown that smoking has a signiﬁcant and negative association with health-related quality
of life (HRQOL). A question remains, however, as to whether this association between smoking and HRQOL
diﬀers by gender or educational level. To examine this question, we extracted data from the 2013 Belgian Health
Interview Survey (n= 5668). HRQOL was assessed using the descriptive system of the EuroQol 5D-5L that
consists of 5 dimensions and the resulting index score. Linear and logistic multivariable regression models were
ﬁtted to estimate the association between HRQOL and smoking for each educational level and gender. Also,
interaction terms were introduced in the full regression models and the Wald test was used to assess model ﬁt.
Our ﬁndings show that among men, there is no signiﬁcant association between smoking and HRQOL, and no
eﬀect modiﬁcation by educational level. Among women, however, daily smokers have shown signiﬁcantly lower
HRQOL scores compared with never smokers, but only among females with a low and intermediate educational
level. The lower EQ-5D index scores among female daily smokers with lower education was due to higher odds of
reporting problems in anxiety/depression, mobility, pain, and usual activities. To conclude, information on the
association between HRQOL and smoking is useful for the development of smoking cessation interventions. Our
ﬁndings suggest the importance of tailoring these interventions to the needs of the women with lower education.
1. Introduction
It is widely documented that tobacco smoking is associated with
various chronic diseases, disability and mortality (CDC, 2017; Van
Oyen et al., 2014). Smoking has also been associated with other mea-
sures of general health and well-being including health-related quality
of life (HRQOL) (Maheswaran et al., 2013; Vogl et al., 2012). Indeed, a
number of studies have examined the association between smoking and
HRQOL in diverse settings and populations and using diﬀerent ways to
measure HRQOL. Based on a recent review of these studies, it could be
concluded that smokers have worse HRQOL than non-smokers and that
the strength of the association increases with the number of cigarettes
smoked (Goldenberg et al., 2014).
Assessing the association between smoking and HRQOL is important
as HRQOL generates a holistic multidimensional measure of well-being
that encompasses people's evaluation of their physical, mental, emo-
tional and social functioning. It is a measure that goes beyond direct
measures of health and focuses on the impact health status has on
quality of life (Hennessy et al., 1994). Therefore, HRQOL allows a
better understanding of the impact of smoking on well-being, thereby
supplementing the well-known impact of smoking on mortality and
morbidity. HRQOL also allows to provide a positive context for en-
couraging smoking cessation by focusing on the positive gains in quality
of life (Wilson et al., 1999).
HRQOL has also gained signiﬁcant importance on the policy level as
it is often used to inform public health and health care policy. HRQOL
can indeed be used as an input to calculate quality-adjusted life years
(QALYs), one of the most commonly reported measures of beneﬁt in
health economic evaluations (McCaﬀrey et al., 2016). Therefore,
HRQOL can be instrumental in informing economic evaluations of in-
terventions related to tobacco smoking, be it prevention, cessation or
treatment interventions.
The association between smoking and HRQOL has already been well
established. A question still remains however as to whether this asso-
ciation varies by sex and socioeconomic status (SES). This is an im-
portant question since studies have indicated lower HRQOL among
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women and among people with lower SES (Mielck et al., 2013), and
have found important variations by sex and SES in the patterns of
smoking and the health impacts of smoking (Graham et al., 2006;
Pampel and Rogers, 2004; Peters et al., 2015).Such information on a
diﬀerential association between smoking and HRQOL may further re-
ﬁne targeting strategies for smoking cessation interventions (Wilson
et al., 2004), yet few studies have examined this issue. For instance,
some studies analysed whether the association between HRQOL and
smoking diﬀer by gender, but reached inconsistent conclusions (Coste
et al., 2014; Laaksonen et al., 2006; Wilson et al., 2004). No study has
however assessed whether the association between HRQOL and
smoking varies by SES. Nonetheless, a number of studies have shown
that the negative association between HRQOL and chronic diseases
such as hypertension, diabetes and obesity is greater among people
with a lower SES (Kinge and Morris, 2010; Mielck et al., 2014; Staﬀord
et al., 2012).
In this context, the purpose of the current study is to use Belgian
data to explore whether the association between HRQOL and smoking
diﬀers by gender and SES.
2. Methods
2.1. Study population
The Belgian Health Interview Survey (BHIS) is a cross-sectional
household survey that has been periodically organized since 1997. The
participants are selected from the national register through a multistage
stratiﬁed sample of the population. For this study we used data from the
BHIS 2013 and included only participants aged 15 years and older. The
participation rate in the survey was 57% at the household level. The
detailed methodology of the survey is described elsewhere (Demarest
et al., 2013). The ﬁnal sample had a population of 5668 individuals.
Data on demographic information and SES were collected through face-
to-face interviews, whereas HRQOL and smoking were assessed via self-
administered written questionnaires.
2.2. Measures
A three-category variable was used to diﬀerentiate between never
smokers, former smokers and daily smokers. This categorization was
based on two questions: 1) Have you smoked at least 100 cigarettes
(about 5 packs) or the equivalent amount of tobacco in your entire life
(Yes/No)?; 2) Do you smoke at all nowadays (Yes, daily; Yes, occa-
sionally; Not at all)? Only daily smokers were considered as smokers.
Occasional smokers were dropped from the analyses as the number of
people in this category was too small (n= 260) to allow reliable con-
clusions to be drawn.
Educational level was used as a proxy for SES. Educational level was
based on the highest level of education achieved in the household. We
recoded this variable into three categories (UNESCO, 2006): low (lower
secondary education or less), intermediate (higher secondary educa-
tion), and high (higher education).
HRQOL was assessed using the EuroQol 5D-5L (EQ-5D-5L) ques-
tionnaire. It is a standardized and widely used instrument that has been
applied to a broad range of health conditions in diﬀerent populations. A
number of studies have used this instrument to assess the association
between HRQOL and smoking and smoking-related diseases
(Maheswaran et al., 2013; Vogl et al., 2012). The EQ-5D-5L has two
main components: the descriptive system and the visual analogue scale.
In this study we used only the descriptive system, which deﬁnes HRQOL
in terms of ﬁve dimensions (5D): ‘mobility’, ‘self-care’, ‘usual activities’,
‘pain/discomfort’ and ‘anxiety/depression’. Each of these dimensions
has 5 levels (5L) of perceived problems: (level 1) no problems, (level 2)
slight problems, (level 3) moderate problems, (level 4) severe problems,
and (level 5) extreme problems. There are 3125 (55) possible health
states generated by combining one level from each of the dimensions.
For example state 11111 indicates no problems on any of the 5 di-
mensions, while state 12345 indicates no problems with mobility, slight
problems with self-care, moderate problems with doing usual activities,
severe pain or discomfort and extreme anxiety or depression.
Each health state is converted into a single EQ-5D index score using an
algorithm based on public preferences for diﬀerent health states. In Belgium,
such an algorithm is so far only available for the EQ-5D-3L questionnaire (3
levels of responses instead of 5) (Cleemput, 2010). Therefore, using a cross-
walk function, the EuroQoL Group mapped the EQ-5D-5L health states to
EQ-5D-3L health states (Van Hout et al., 2012). Applying both algorithms to
the EQ-5D-5L health states thus resulted in the calculation of an EQ-5D
index score for each respondent, ranging from−0.158 (worst health state)
to 1 (most optimal health state). See more details on the calculation of the
ED-5D-5L index score in the supplementary ﬁles.
2.3. Data analysis
Firstly, descriptive summary statistics by age, sex and educational
level were calculated for the EQ-5D index score and for each of the 5
dimensions.
Secondly, multivariable linear regression modelling was used to
study the association between the EQ-5D index score and smoking
while controlling for a number of covariates. Logistic regression mod-
elling was performed to study the association of each of the dimensions,
dichotomized into ‘no problems’ (level 1) and ‘any problem’ (levels 2 to
5), with smoking while controlling for the same covariates. The choice
of covariates was guided by previous studies in the ﬁeld. Therefore, in
addition to including age, gender and education in these models, we
controlled for marital status (married or legally cohabiting, widowed,
divorced, never married), country of birth (Belgian, Non-Belgian but
citizen of the European Union, non-Belgian and citizen of other coun-
tries), region of residence (Brussels, Flemish Region, Walloon Region),
obesity (subjects with a Body Mass Index greater than or equal to 30
were considered obese), healthy eating deﬁned as eating at least 5
portions of fruit and vegetables daily (yes/no) and alcohol over-
consumption deﬁned as more than 14 drinks a week for women and 21
drinks a week for men (yes/no). We controlled for socio-demographic
factors as these have an important impact on HRQOL and on smoking.
We controlled for health behaviour factors as unhealthy behaviours
tend to cluster. The variance inﬂation factor for the relationship be-
tween smoking and the other included covariates equalled 1.06, in-
dicating no risk of multicollinearity.
Thirdly, to assess eﬀect modiﬁcation by gender, interaction terms
between smoking and gender were introduced in the full regression
models and a Wald test was used to evaluate whether the inclusion of
the interaction terms would improve the ﬁt of the model. If the Wald
test was statistically signiﬁcant, then we stratiﬁed the regression ana-
lysis by gender. The same approach was used to assess eﬀect mod-
iﬁcation by educational level.
All analyses were weighted and have accounted for the complex
study design of the BHIS. Conﬁdence intervals were calculated at the
95% level. The analyses were performed in STATA 13 using appropriate
svy commands.
3. Results
The mean EQ-5D index score was 0.812, ranging from −0.158
(worst health state) to 1 (most optimal health state). When considering
the separate dimensions, the percentage of individuals who reported
any problem varied from 7% for self-care to 18% for usual activity, 18%
for mobility, 27% for anxiety/depression and 50% for pain/discomfort.
As shown in Tables 1 and 2, the EQ-5D score was signiﬁcantly lower
among daily smokers compared with never smokers, even after ad-
justing for age and for a series of covariates (coeﬃcient of−0.055 with
a 95% CI of−0.074;−0.035). As shown in Table 2, for all dimensions
except for self-care, the likelihood of reporting any problem was
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signiﬁcantly higher among daily smokers compared with never smo-
kers. Former smokers had signiﬁcantly higher odds of reporting pain/
discomfort compared with never smokers. Also, as seen in Table 1,
compared with daily smokers, former smokers had a signiﬁcantly
higher EQ-5D index score and a lower probability of reporting problems
on the usual activity and anxiety/depression dimensions.
3.1. Gender diﬀerences
The association between the EQ-5D index score and smoking was
signiﬁcantly diﬀerent by gender as shown by the statistically signiﬁcant
Wald test (p= 0.0015). The stratiﬁed analysis displayed in Table 2
shows that after adjusting for all considered covariates, the association
between the EQ-5D index score and smoking remained signiﬁcant for
women (coeﬃcient of−0.091 with a 95% CI of−0.119;−0.063) but
not for men (coeﬃcient of−0.021 with a 95% CI of−0.046; 0.004). In
terms of dimensions, compared with never smokers, female daily
smokers had higher odds of reporting any problem in all domains ex-
cept for self-care. Among males, after adjusting for the covariates, no
association with daily smoking was observed for any of the dimensions,
in line with the ﬁndings for the EQ-5D index score.
3.2. Educational and gender diﬀerences
The association between the EQ-5D index score and smoking was
signiﬁcantly diﬀerent by educational level for women (p= 0.0043) but
not for men (p= 0.3199).
The regression analyses in Table 3 conﬁrmed the lack of association
between smoking and HRQOL among males. The ﬁndings among
women (Table 4) showed that female daily smokers with a low and
intermediate educational level have signiﬁcantly lower EQ-5D index
scores than their never smoker counterparts (coeﬃcients respectively of
−0.106 (95% CI −0.179; −0.033) and −0.114 (95% CI −0.153;
−0.074)). Among highly educated women, daily smokers did not show
any statistically signiﬁcant diﬀerence in the EQ-5D index score com-
pared with never smokers, but former smokers showed a signiﬁcantly
lower EQ-5D score compared with never smokers (coeﬃcient of
−0.040 with a 95% CI of −0.071; −0.009). The signiﬁcantly lower
EQ-5D index among the female daily smokers with a low educational
level compared with their never smoker counterparts was due to the
higher odds of reporting problems in mobility and anxiety/depression.
For female daily smokers with an intermediate educational level,
problems with mobility, usual activity, pain/discomfort and anxiety/
depression were important contributors. For highly educated female
former smokers, problems with pain/discomfort were the signiﬁcant
contributors. However, for the models of the 5 dimensions, the Wald
tests for the interaction between smoking and educational level were
not statistically signiﬁcant.
In addition, as a sensitivity analysis, we added in our multivariable
models a number of variables to assess the presence of a number of
chronic diseases in the past 12 months (asthma, bronchitis, heart dis-
eases, diabetes, hypertension, cancer) and the presence of a depression
in the past 12 months. The results of these additional models (see Table
A in the supplementary ﬁles) are comparable to the results presented
here.
4. Discussion
The aim of this study was to examine whether the association be-
tween smoking and HRQOL varies by gender and educational level.
Among men, we found no signiﬁcant association between smoking and
HRQOL, and no eﬀect modiﬁcation by educational level. Among
women, however, daily smokers have shown signiﬁcantly lower
HRQOL scores compared with never smokers, but only among females
with a low and intermediate educational level. The lower EQ-5D index
among female smokers with a lower educational level compared with
never smokers was due to higher odds of reporting problems in anxiety/
depression, mobility, pain and usual activities. We also found a sig-
niﬁcantly lower EQ-5D score for former smokers compared with never
smokers, but only among highly educated women.
Interpreting the clinical importance of diﬀerences in EQ-5D scores is
not straightforward. Indeed, no explicit statement has been made re-
garding what change in the EQ-5D score constitutes a clinically im-
portant diﬀerence. However, a minimally important diﬀerence (MID) of
0.074 points has been previously proposed in the literature (Walters
and Brazier, 2005). This estimation was based on a series of conditions
(leg ulcer, back pain, early rheumatoid arthritis, limb reconstruction,
osteoarthritis, irritable bowel syndrome and chronic obstructive lung
disease), but has been used to assess EQ-5D scores for health related
behaviours (Maheswaran et al., 2013). This MID suggests that the lower
EQ-5D scores observed in our study for female daily smokers with low
and intermediate educational level (respectively −0.106 and−0.114)
can be regarded as clinically signiﬁcant. It is important however to
interpret this threshold with caution (Kinge and Morris, 2010), as it was
Table 1
Mean EQ-5D index score and prevalence of any problem on the EQ-5D dimensions by sociodemographic characteristics and smoking status, Belgian Health Interview Survey, 2013.
% of N EQ-5D score Mobility Self-care Usual activity Pain/discomfort Anxiety/depression
(N = 5668) Meana 95%CI %a 95%CI %a 95%CI %a 95%CI %a 95%CI %a 95%CI
Sex
Male 47.25 0.835 0.825–0.844 15.45 13.76–17.32 5.48 4.40–6.81 14.87 13.17–16.74 46.67 44.12–49.24 22.42 20.40–24.59
Female 52.75 0.790 0.780–0.801 21.19 19.22–23.30 8.32 7.02–9.83 20.70 18.78–22.75 53.53 51.00–56.05 30.57 28.43–32.81
Age
15–24 9.71 0.898 0.883–0.913 4.51 2.80–7.19 0.48 0.12–7.90 6.55 4.48–9.50 28.76 23.78–34.33 21.78 17.25–27.11
25–44 31.77 0.851 0.838–0.863 9.80 7.89–12.11 2.67 1.66–4.27 12.81 10.74–15.20 42.30 39.04–45.62 24.43 21.84–27.21
45–64 35.52 0.800 0.788–0.811 17.60 15.34–20.11 6.32 4.95–8.02 17.68 15.54–20.04 55.40 52.36–58.40 29.85 27.23–32.61
65+ 23.01 0.730 0.712–0.748 39.70 36.11–43.42 17.66 15.03–20.65 31.58 28.19–35.18 64.49 60.86–67.96 27.23 24.09–30.62
Educational level
Low 22.66 0.733 0.714–0.752 33.38 29.88–37.07 17.43 14.62–20.65 32.01 28.59–35.63 59.63 55.89–63.25 32.53 29.00–36.26
Intermediate 31.90 0.815 0.802–0.827 18.67 16.45–21.11 5.40 4.28–6.80 18.72 16.42–21.26 49.32 45.95–52.70 27.03 24.25–29.99
High 45.44 0.848 0.838–0.857 11.01 9.32–12.97 3.03 2.13–4.29 10.45 8.96–12.14 46.37 43.53–49.22 23.54 21.37–25.86
Smoking status
Daily 19.83 0.772 0.755–0.790 21.28 18.35–24.54 6.62 4.99–8.73 23.32 20.20–26.76 55.14 51.18–59.04 37.52 33.75–41.44
Former 21.74 0.809 0.795–0.824 20.47 17.47–23.83 6.55 4.86–8.77 17.32 14.65–20.35 55.00 51.12–58.82 25.04 22.10–28.24
Never 58.43 0.826 0.816–0.836 16.69 14.97–18.57 7.22 6.03–8.64 16.30 14.62–18.14 46.75 44.27–49.24 23.64 21.69–25.70
Total 100.00 0.812 0.804–0.819 18.43 17.06–19.89 6.95 6.07–7.96 17.90 16.56–19.31 50.23 48.33–52.13 26.66 25.10–28.27
a Weighted and accounted for the complex study design of the Belgian Health Interview Survey.
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derived from clinical studies that were designed to assess the eﬃcacy of
treatment interventions. Furthermore, the MIDs may vary by condition
and none of the studies focused speciﬁcally on smoking.
Our ﬁnding of a signiﬁcant negative association between HRQOL
and smoking among lower SES women is compatible with ﬁndings in
the literature showing that women may be more susceptible to the
health impacts of smoking than men. For instance, in a large US study,
women who smoked had higher odds of having poor self-rated health,
heart disease and current asthma compared with male smokers
(Syamlal et al., 2014). A meta-analysis has shown that although
smoking considerably increased the risk of coronary heart disease in
both sexes, women who smoke have a 25% higher excess relative risk of
coronary heart disease compared with men who smoke (Huxley and
Woodward, 2011). Another meta-analysis concluded that the increase
in mortality and morbidity risk from low to high levels of smoking was
greater for females than for males (Mucha et al., 2006). Furthermore, it
is important to highlight that even after controlling for a number of
chronic diseases (asthma, bronchitis, heart diseases, diabetes, hy-
pertension, cancer, asthma) in the models (see Table A in the
supplementary ﬁles), the negative association between HRQOL and
smoking among women with a low and intermediate educational level
was still statistically signiﬁcant and the coeﬃcients were higher than
the clinical threshold of 0.074 points.
Smoking has also been found to have higher psychosocial impacts
on women. For instance, it has been reported that women's smoking
played an important role in their life. Women often encountered harsh
consequences from smoking such as poor self-image, a sense of in-
feriority and a sense of having lost control over their own actions, while
this was not the case for men who reported fewer negative con-
sequences from smoking and perceived their smoking largely as an
unproblematic habit (Sohlberg, 2015). Another study has shown that
female smokers who unsuccessfully try to quit were more likely to re-
port physical and mental distress than those who did not try to quit
smoking, while no signiﬁcant diﬀerence in the frequency of physical
and mental distress was reported by male smokers who tried to quit
compared to those who did not (McClave et al., 2009). This higher
psychosocial impact among women further supports our ﬁndings as the
EQ-5D instrument accounts for mental health.
Table 3
Association of HRQOL indicators with smoking status, stratiﬁed by educational level, Males, Belgian Health Interview Survey, 2013.
Smoking status EQ-5D score Mobility Self-carec Usual activity Pain/discomfort Anxiety/depression
Coeﬃcienta 95%CI ORb 95%CI ORb 95%CI ORb 95%CI ORb 95%CI ORb 95%CI
Low education (n= 582)
Daily smokers 0.041 (−0.012; 0.095) 0.89 (0.45; 1.76) 0.43 (0.19; 0.95) 0.59 (0.32; 1.11) 0.64 (0.35; 1.14) 0.95 (051; 1.74)
Former smokers 0.015 (−0.044; 0.074) 1.18 (0.64; 2.18) 0.53 (0.22; 1.27) 0.72 (0.38; 1.37) 1.07 (0.60; 1.91) 0.92 (0.48; 1.76)
Never smokers Ref Ref 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Intermediate education (n= 860)
Daily smokers −0.036 (−0.073; 0.001) 1.66 (0.95; 2.91) 1.03 (0.39; 2.68) 2.25 (1.26; 4.02) 1.26 (0.79; 2.00) 2.15 (1.25; 3.68)
Former smokers 0.002 (−0.039; 0.043) 1.10 (0.59; 2.05) 0.68 (0.26; 1.81) 0.95 (0.51; 1.74) 0.88 (0.55; 1.41) 1.29 (0.73; 2.28)
Never smokers Ref Ref 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
High education (n= 1236)
Daily smokers −0.033 (−0.073; 0.007) 1.37 (0.50; 3.76) 1.03 (0.16; 6.89) 1.01 (0.42; 2.43) 1.74 (1.04; 2.90) 1.18 (0.68; 2.06)
Former smokers −0.021 (−0.047; 0.005) 1.26 (0.74; 2.15) 1.25 (0.49; 3.20) 1.39 (0.79; 2.42) 1.34 (0.92; 1.96) 1.42 (0.91; 2.21)
Never smokers Ref Ref 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
a Regression coeﬃcient based on a multivariate linear regression fully adjusted for age, civil status, country of birth, region, household type, obesity, eating habits and alcohol
consumption.
b Odds ratio based on a multivariate logistic regression fully adjusted for the same covariates.
c Very few participants had any problem in self-care and in some cases a number of variables predicted the outcome perfectly. As a result, STATA dropped a number of observations in
this model and the N for the males in the three educational categories are respectively: 503, 746 and 1198.
Table 4
Association of HRQOL indicators with smoking status, stratiﬁed by educational level, Females, Belgian Health Interview Survey, 2013.
Smoking status EQ-5D score Mobility Self-carec Usual activity Pain/discomfort Anxiety/depression
Coeﬃcienta 95%CI ORb 95%CI ORb 95%CI ORb 95%CI ORb 95%CI ORb 95%CI
Low education (n= 702)
Daily smokers −0.106 (−0.179; −0.033) 1.91 (1.02; 3.58) 1.22 (0.57; 2.61) 1.56 (0.85; 2.87) 1.30 (0.72; 2.35) 3.05 (1.72; 5.42)
Former smokers 0.005 (−0.066; 0.076) 1.27 (0.61; 2.67) 0.74 (0.25; 2.20) 0.89 (0.40; 1.97) 1.71 (0.86; 3.40) 0.83 (0.40; 1.70)
Never smokers Ref Ref 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Intermediate education (n= 948)
Daily smokers −0.114 (−0.153; −0.074) 2.30 (1.30; 4.07) 2.02 (0.87; 4.70) 2.43 (1.45; 4.09) 2.49 (1.56; 3.96) 3.19 (1.94; 5.27)
Former smokers 0.012 (−0.028; 0.052) 1.01 (0.50; 2.03) 1.27 (0.47; 3.45) 1.06 (0.54; 2.08) 1.06 (0.63; 1.77) 0.95 (0.55; 1.65)
Never smokers Ref Ref 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
High education (n= 1340)
Daily smokers −0.037 (−0.075; 0.000) 1.06 (0.45; 2.46) 0.83 (0.17; 4.04) 1.80 (0.88; 3.67) 1.30 (0.78; 2.16) 1.60 (0.97; 2.62)
Former smokers −0.040 (−0.071; −0.009) 1.73 (0.96; 3.13) 1.45 (0.67; 3.39) 1.45 (0.83; 2.53) 1.59 (1.09; 2.34) 1.44 (0.98; 2.12)
Never smokers Ref Ref 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
a Regression coeﬃcient based on a multivariate linear regression fully adjusted for age, civil status, country of birth, region, household type, obesity, eating habits and alcohol
consumption.
b Odds ratio based on a multivariate logistic regression fully adjusted for.
c Very few participants had any problem in self-care and in some cases a number of variables predicted the outcome perfectly. As a result, STATA dropped a number of observations in
this model and the N for the females in the three educational categories are respectively 639, 783, 1219.
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However, are women with a low SES more susceptible to the health
impact of smoking than women with a high SES?
It has been hypothesized that due to their favorable social circum-
stances and better health status, people with a high SES may be less
susceptible to the harmful eﬀect of tobacco smoking compared with
people with a low SES who already experience multiple threats to their
health (e.g., poor diet, low physical activity, high stress, exposure to air
pollution at home or at work, etc.) (Pampel and Rogers, 2004). There is
still no consensus in the literature about such a diﬀerential health im-
pact on smoking (Charafeddine et al., 2012), but a recent study has
assessed whether the educational level aﬀects the association between
smoking and healthy life expectancy among men and women in Den-
mark (Bronnum-Hansen and Jeune, 2015). They found that the diﬀer-
ence in healthy life expectancy between smokers and non-smokers was
larger for women with a lower educational level compared with women
with a higher educational level. The inverse was true for men; the
diﬀerence in healthy life expectancy between smokers and non-smokers
was larger for men with a higher educational level. They concluded that
women with low education were more vulnerable to the eﬀects of
smoking than highly educated women, while highly educated men were
found to be more vulnerable to the eﬀects of smoking than their
counterparts with lower education.
4.1. Limitations
A number of study limitations need to be acknowledged. A ﬁrst
potential limitation is the use of self-reported data on smoking.
Although the validity of self-reported smoking has been questioned, a
number of studies have found the validity of self-reported smoking to be
high in the general population and among various subgroups including
educational categories (Rebagliato, 2002; Vartiainen et al., 2002). Still,
it cannot be excluded that a bias has been generated due to systematic
diﬀerentials in under-reporting by socio-demographic groups (Fisher
et al., 2008; West et al., 2007). Previous studies have found that people
with a lower educational level may underreport their smoking status
(Caraballo et al., 2001; Wagenknecht et al., 1992). Sensitivity to the
social stigma associated with smoking has been cited as one reason for
this underreporting.
In addition, many of the studies on HRQOL and smoking have found
that as smoking intensity increases, HRQOL decreases. In our analyses,
we did not include smoking intensity. However, it could be that women
with a low and intermediate SES are heavier smokers compared to
women with a high SES, and that this contributed to the diﬀerential
eﬀect that we observed. Therefore, we performed additional analyses
(see Table B in the supplementary ﬁles) using a smoking indicator that
diﬀerentiated between heavy smokers, light smokers and non-smokers.
The results of this sensitivity analysis were in line with the results
published in this manuscript.
A ﬁnal limitation is the use of cross-sectional data that does not
allow determining whether the associations detected reﬂect a causal
relationship. This issue is especially of importance for the dimension
anxiety/depression as it is well acknowledged in the literature that
those with a mental disorder are more likely to smoke (Mykletun et al.,
2008). Still, recent longitudinal studies have reported a cause-eﬀect
relationship between cigarette smoking and depression in which to-
bacco use increases the risks of depression symptoms (Argondizo Dos
Santos et al., 2010). Further longitudinal studies would allow de-
termining a causal association between smoking and HRQOL.
4.2. Implications and conclusion
The results of this study have clinical as well as policy relevance. In
the clinical ﬁeld, information on HRQOL and smoking is useful for the
development of smoking cessation interventions. Studies have shown
that women living in disadvantaged socioeconomic circumstances are
particularly likely to become regular smokers and encounter more
challenges in quitting than the general population (Hemsing et al.,
2015). Qualitative studies (Greaves, 2015; Greaves and Hemsing, 2009)
have provided some insights into the reasons why women with lower
SES smoke, including the need to control anger, to manage stress, to
reward themselves and to facilitate social relationships. In comparison
to these short-term beneﬁts of tobacco smoking, a future health gain
from quitting may seem less important. Findings from our study provide
a positive context to encourage smoking cessation by focusing on the
positive gains in the current quality of life. This is especially the case
since our ﬁndings show that the HRQOL of female former smokers with
low SES is not signiﬁcantly diﬀerent from the HRQOL of female never
smokers with low SES. On the policy level, our ﬁndings conﬁrm the
importance of accounting for gender and SES when undertaking eco-
nomic evaluations of smoking cessation interventions. Given that
HRQOL is used as input for cost-eﬀectiveness analyses, our ﬁnding of a
large and signiﬁcant reduction in HRQOL among women with low SES
suggests a greater gain from smoking cessation in this group. Therefore,
developing eﬀective smoking cessation programs for this subpopulation
is a very critical, albeit challenging (Hemsing et al., 2015), task. Such
programs should provide diﬀerent forms of support as our ﬁndings have
shown that four of the ﬁve EQ-5D dimensions (depression/anxiety,
mobility, usual activity and pain/discomfort) were signiﬁcant con-
tributors to the lower HRQOL among this group.
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